GAD1 and type 1 diabetes mellitus: On the other hand, treating STZ-induced T1DM mice with bone marrow cells derived from either naïve or diabetic mice led to an increase in serum levels of ZnT8, IA-2, and GAD protein, while decreasing total immunoglobulin (Ig), IAA, and ICA autoantibody levels.